News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,123 Results
Type
Article (41522)
Company Profile (263)
Press Release (690322)
Multimedia
Podcasts (92)
Webinars (20)
Section
Business (205062)
Career Advice (2034)
Deals (35610)
Drug Delivery (130)
Drug Development (81598)
Employer Resources (173)
FDA (16541)
Job Trends (14989)
News (347189)
Policy (32778)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2607)
Accelerated approval (48)
Adcomms (26)
Allergies (171)
Alliances (49642)
ALS (211)
Alzheimer's disease (1801)
Antibody-drug conjugate (ADC) (450)
Approvals (16932)
Artificial intelligence (669)
Autoimmune disease (295)
Automation (56)
Bankruptcy (362)
Best Places to Work (11639)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (170)
Bladder cancer (196)
Brain cancer (72)
Breast cancer (755)
Cancer (5847)
Cardiovascular disease (475)
Career advice (1728)
Career pathing (44)
CAR-T (333)
CDC (56)
Celiac Disease (3)
Cell therapy (904)
Cervical cancer (47)
Clinical research (70927)
Collaboration (2072)
Company closure (5)
Compensation (1405)
Complete response letters (80)
COVID-19 (2747)
CRISPR (108)
C-suite (1138)
Cystic fibrosis (152)
Data (7966)
Decentralized trials (3)
Denatured (28)
Depression (161)
Dermatology (87)
Diabetes (590)
Diagnostics (6937)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (323)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (285)
Earnings (92229)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119785)
Executive appointments (1083)
FDA (20291)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1733)
Gene editing (234)
Generative AI (56)
Gene therapy (726)
GLP-1 (1057)
Government (4733)
Grass and pollen (6)
Guidances (408)
Healthcare (19025)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (290)
Immuno-oncology (93)
Indications (196)
Infectious disease (3089)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (292)
Interviews (320)
IPO (16678)
IRA (50)
Job creations (3648)
Job search strategy (1432)
JPM (58)
Kidney cancer (19)
Labor market (102)
Layoffs (564)
Leadership (41)
Legal (7958)
Liver cancer (100)
Longevity (32)
Lung cancer (766)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1058)
MASH (190)
Medical device (13969)
Medtech (14096)
Mergers & acquisitions (20186)
Metabolic disorders (1510)
mRNA (208)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (419)
Neuropsychiatric disorders (105)
Neuroscience (3315)
Neurotech (1)
NextGen: Class of 2026 (6529)
Non-profit (4531)
Now hiring (78)
Obesity (706)
Opinion (289)
Ovarian cancer (222)
Pain (257)
Pancreatic cancer (308)
Parkinson's disease (362)
Partnered (33)
Patents (599)
Patient recruitment (677)
Peanut (62)
People (59656)
Pharmaceutical (58)
Pharmacy benefit managers (32)
Phase 1 (22102)
Phase 2 (31252)
Phase 3 (23250)
Pipeline (8860)
Policy (319)
Postmarket research (2570)
Preclinical (9444)
Press Release (64)
Prostate cancer (305)
Psychedelics (54)
Radiopharmaceuticals (324)
Rare diseases (1084)
Real estate (5973)
Recruiting (70)
Regulatory (25456)
Reports (56)
Research institute (2419)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (176)
Series A (289)
Series B (213)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3647)
State (2)
Stomach cancer (18)
Supply chain (128)
Tariffs (87)
The Weekly (62)
Vaccines (1099)
Venture capital (109)
Weight loss (453)
Women's health (129)
Worklife (20)
Date
Today (93)
Last 7 days (661)
Last 30 days (3521)
Last 365 days (30167)
2026 (12951)
2025 (30205)
2024 (35241)
2023 (40108)
2022 (51217)
2021 (55758)
2020 (54132)
2019 (46588)
2018 (35055)
2017 (32139)
2016 (31537)
2015 (37595)
2014 (31361)
2013 (26393)
2012 (28639)
2011 (29295)
2010 (27364)
Location
Africa (743)
Alabama (93)
Alaska (7)
Arizona (350)
Arkansas (14)
Asia (39793)
Australia (6528)
California (13358)
Canada (3789)
China (1350)
Colorado (569)
Connecticut (579)
Delaware (411)
Europe (86074)
Florida (2003)
Georgia (430)
Hawaii (3)
Idaho (62)
Illinois (1054)
India (90)
Indiana (602)
Iowa (23)
Japan (540)
Kansas (131)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1600)
Massachusetts (9539)
Michigan (366)
Minnesota (725)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3506)
New Mexico (30)
New York (3491)
North Carolina (1694)
North Dakota (9)
Northern California (6700)
Ohio (399)
Oklahoma (23)
Oregon (41)
Pennsylvania (2687)
Puerto Rico (29)
Rhode Island (50)
South America (1114)
South Carolina (86)
South Dakota (2)
Southern California (5275)
Tennessee (214)
Texas (2130)
United States (47115)
Utah (398)
Vermont (1)
Virginia (323)
Washington D.C. (80)
Washington State (1063)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
732,123 Results for "collagen matrix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
StimLabs® Announces the Launch of Architect, a Novel Advanced Collagen Matrix Device for Wound Care
March 4, 2026
·
2 min read
Press Releases
Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials
January 23, 2026
·
6 min read
Press Releases
Royal Biologics Announces FDA Clearance for Fibrinet® PRF Wound Matrix for the Management of Cutaneous Wounds
April 7, 2026
·
4 min read
Press Releases
StimLabs® Announces FDA 510(k) Clearance for DermaForm™, a Collagen Scaffold Particulate Wound Care Device
February 12, 2026
·
2 min read
Press Releases
Royal Biologics Announces Strategic Partnership with Jellagen (UK) to Bring Jellyfish-Derived Collagen Type Zero to the U.S. Regenerative Medicine Market
February 24, 2026
·
5 min read
Press Releases
Taiwan’s ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients
April 13, 2025
·
2 min read
Biotech Bay
Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences
Collagen Matrix, Inc. announced it has changed its name to Regenity Biosciences and unveiled a new visual identity and website.
March 28, 2023
·
3 min read
Press Releases
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
August 1, 2024
·
2 min read
Pharm Country
Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market
Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company (“Collagen Matrix” or “the Company”), announced today its 510(k) Clearance for a new Fibrillar Collagen Wound Dressing.
June 28, 2022
·
3 min read
Deals
Collagen Matrix Acquires Polyganics
Collagen Matrix, Inc., a global leader in regenerative medicine and a Linden Capital Partners portfolio company, announced the acquisition of Polyganics, B.V. Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices.
October 5, 2022
·
5 min read
1 of 73,213
Next
